Rho GTPase signaling promotes constitutive expression and release of TGF-β2 by human trabecular meshwork cells

Experimental Eye Research

Volumn 146, Issue , 2016, Pages 95-102

  Pervan, Cynthia L ^a,b   Lautz, Jonathan D ^a,b   Blitzer, Andrea L ^a,c   Langert, Kelly A ^a   Stubbs, Evan B ^a,b  

^a HINES VA HOSPITAL   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Glaucoma; Intraocular pressure; Rho GTPase; TGF 2; Trabecular meshwork

Indexed keywords

EXOENZYME C3; GGTI 298; MEVINOLIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA2; RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR EYE SEGMENT; ARTICLE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INTRAOCULAR PRESSURE; NONHUMAN; OPEN ANGLE GLAUCOMA; PERFUSION; PIG; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PRENYLATION; PROTEIN PROCESSING; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TRABECULAR MESHWORK; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; REAL-TIME POLYMERASE CHAIN REACTION; RHO GTP-BINDING PROTEINS; RNA; SIGNAL TRANSDUCTION; SWINE; TRABECULAR MESHWORK; TRANSFORMING GROWTH FACTOR BETA2;

EID: 84953432325     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2015.12.010     Document Type: Article

References (56)

1. Bachmann B., Birke M., Kook D., Eichhorn M., Lutjen-Drecoll E. Ultrastructural and biochemical evaluation of the porcine anterior chamber perfusion model. Invest Ophthalmol. Vis. Sci. 2006, 47:2011-2020.
2. Bhattacharya S.K., Gabelt B.T., Ruiz J., Picciani R., Kaufman P.L. Cochlin expression in anterior segment organ culture models after TGFbeta2 treatment. Invest Ophthalmol. Vis. Sci. 2009, 50:551-559.
3. Cao Y., Houren W., Da B., Li Z. Transforming growth factor-β2 gene cloning and protein expression in human trabecular meshwork cells. J. Huazhong Univ. Sci. Technol. Med. Sci. 2003, 23:85-87.
4. Charron F., Tsimiklis G., Arcand M., Robitaille L., Liang Q., Molkentin J.D., Meloche S., Nemer M. Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoA. Genes Dev. 2001, 15:2702-2719.
5. Cordeiro M.F., Mead A., Ali R.R., Alexander R.A., Murray S., Chen C., York-Defalco C., Dean N.M., Schultz G.S., Khaw P.T. Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome. Gene Ther. 2003, 10:59-71.
6. Fleenor D.L., Shepard A.R., Hellberg P.E., Jacobson N., Pang I.H., Clark A.F. TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure. Invest Ophthalmol. Vis. Sci. 2006, 47:226-234.
7. Franceschetti T., Kessler C.B., Lee S.K., Delany A.M. miR-29 promotes murine osteoclastogenesis by regulating osteoclast commitment and migration. J. Biol. Chem. 2013, 288:33347-33360.
8. Friedman D.S., Wolfs R.C., O'Colmain B.J., Klein B.E., Taylor H.R., West S., Leske M.C., Mitchell P., Congdon N., Kempen J. Prevalence of open-angle glaucoma among adults in the United States. Arch. Ophthalmol. 2004, 122:532-538.
9. Fuchshofer R., Stephan D.A., Russell P., Tamm E.R. Gene expression profiling of TGFbeta2- and/or BMP7-treated trabecular meshwork cells: identification of Smad7 as a critical inhibitor of TGF-beta2 signaling. Exp. Eye Res. 2009, 88:1020-1032.
10. Fuchshofer R., Welge-Lussen U., Lutjen-Drecoll E. The effect of TGF-beta2 on human trabecular meshwork extracellular proteolytic system. Exp. Eye Res. 2003, 77:757-765.
11. Fuchshofer R., Yu A.H., Welge-Lussen U., Tamm E.R. Bone morphogenetic protein-7 is an antagonist of transforming growth factor-beta2 in human trabecular meshwork cells. Invest Ophthalmol. Vis. Sci. 2007, 48:715-726.
12. Gottanka J., Chan D., Eichhorn M., Lutjen-Drecoll E., Ethier C.R. Effects of TGF-beta2 in perfused human eyes. Invest Ophthalmol. Vis. Sci. 2004, 45:153-158.
13. Han H., Wecker T., Grehn F., Schlunck G. Elasticity-dependent modulation of TGF-beta responses in human trabecular meshwork cells. Invest Ophthalmol. Vis. Sci. 2011, 52:2889-2896.
14. Hill C.S., Wynne J., Treisman R. The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 1995, 81:1159-1170.
15. Hill L.J., Mead B., Blanch R.J., Ahmed Z., De Cogan F., Morgan-Warren P.J., Mohamed S., Leadbeater W., Scott R.A., Berry M., Logan A. Decorin reduces intraocular pressure and retinal ganglion cell loss in rodents through fibrolysis of the scarred trabecular meshwork. Invest Ophthalmol. Vis. Sci. 2015, 56:3743-3757.
16. Inatani M., Tanihara H., Katsuta H., Honjo M., Kido N., Honda Y. Transforming growth factor-beta 2 levels in aqueous humor of glaucomatous eyes. Graefes Arch. Clin. Exp. Ophthalmol. 2001, 239:109-113.
17. Keller K.E., Bradley J.M., Acott T.S. Differential effects of ADAMTS-1, -4, and -5 in the trabecular meshwork. Invest Ophthalmol. Vis. Sci. 2009, 50:5769-5777.
18. Khaw P., Grehn F., Hollo G., Overton B., Wilson R., Vogel R., Smith Z. A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy. Ophthalmology 2007, 114:1822-1830.
19. Kingsley-Kallesen M.L., Kelly D., Rizzino A. Transcriptional regulation of the transforming growth factor-beta2 promoter by cAMP-responsive element-binding protein (CREB) and activating transcription factor-1 (ATF-1) is modulated by protein kinases and the coactivators p300 and CREB-binding protein. J. Biol. Chem. 1999, 274:34020-34028.
20. Langert K.A., Pervan C.L., Stubbs E.B. Novel role of Cdc42 and RalA GTPases in TNF-alpha mediated secretion of CCL2. Small GTPases 2014, 5.
21. Langert K.A., Von Zee C.L., Stubbs E.B. Cdc42 GTPases facilitate TNF-alpha-mediated secretion of CCL2 from peripheral nerve microvascular endoneurial endothelial cells. J. Peripher Nerv. Syst. 2013, 18:199-208.
22. Luna C., Li G., Qiu J., Epstein D.L., Gonzalez P. Cross-talk between miR-29 and transforming growth factor-betas in trabecular meshwork cells. Invest Ophthalmol. Vis. Sci. 2011, 52:3567-3572.
23. Marinissen M.J., Chiariello M., Gutkind J.S. Regulation of gene expression by the small GTPase Rho through the ERK6 (p38 gamma) MAP kinase pathway. Genes Dev. 2001, 15:535-553.
24. McDowell C.M., Tebow H.E., Wordinger R.J., Clark A.F. Smad3 is necessary for transforming growth factor-beta2 induced ocular hypertension in mice. Exp. Eye Res. 2013, 116:419-423.
25. Mead A.L., Wong T.T., Cordeiro M.F., Anderson I.K., Khaw P.T. Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery. Invest Ophthalmol. Vis. Sci. 2003, 44:3394-3401.
26. Min S.H., Lee T.I., Chung Y.S., Kim H.K. Transforming growth factor-beta levels in human aqueous humor of glaucomatous, diabetic and uveitic eyes. Korean J. Ophthalmol. 2006, 20:162-165.
27. Namachivayam K., MohanKumar K., Arbach D., Jagadeeswaran R., Jain S.K., Natarajan V., Mehta D., Jankov R.P., Maheshwari A. All-trans retinoic acid induces TGF-beta2 in intestinal epithelial cells via RhoA- and p38alpha MAPK-mediated activation of the transcription factor ATF2. PLoS One 2015, 10:e0134003.
28. Ochiai Y., Ochiai H. Higher concentration of transforming growth factor-beta in aqueous humor of glaucomatous eyes and diabetic eyes. Jpn. J. Ophthalmol. 2002, 46:249-253.
29. Ozcan A.A., Ozdemir N., Canataroglu A. The aqueous levels of TGF-beta2 in patients with glaucoma. Int. Ophthalmol. 2004, 25:19-22.
30. Park S.Y., Lee J.H., Ha M., Nam J.W., Kim V.N. miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat. Struct. Mol. Biol. 2009, 16:23-29.
31. Pasquale L.R., Dorman-Pease M.E., Lutty G.A., Quigley H.A., Jampel H.D. Immunolocalization of TGF-beta 1, TGF-beta 2, and TGF-beta 3 in the anterior segment of the human eye. Invest Ophthalmol. Vis. Sci. 1993, 34:23-30.
32. Pattabiraman P.P., Maddala R., Rao P.V. Regulation of plasticity and fibrogenic activity of trabecular meshwork cells by Rho GTPase signaling. J. Cell Physiol. 2014, 229:927-942.
33. Pattabiraman P.P., Rao P.V. Mechanistic basis of Rho GTPase-induced extracellular matrix synthesis in trabecular meshwork cells. Am. J. Physiol. Cell Physiol. 2010, 298:C749-C763.
34. Picht G., Welge-Luessen U., Grehn F., Lutjen-Drecoll E. Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch. Clin. Exp. Ophthalmol. 2001, 239:199-207.
35. Quigley H.A., Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 2006, 90:262-267.
36. Rao P.V., Peterson Y.K., Inoue T., Casey P.J. Effects of pharmacologic inhibition of protein geranylgeranyltransferase type I on aqueous humor outflow through the trabecular meshwork. Invest Ophthalmol. Vis. Sci. 2008, 49:2464-2471.
37. Roberts A.B., Kim S.J., Noma T., Glick A.B., Lafyatis R., Lechleider R., Jakowlew S.B., Geiser A., O'Reilly M.A., Danielpour D., et al. Multiple forms of TGF-beta: distinct promoters and differential expression. Ciba Found. Symp. 1991, 157(7-15):15-28.
38. Robertson J.V., Golesic E., Gauldie J., West-Mays J.A. Ocular gene transfer of active TGF-beta induces changes in anterior segment morphology and elevated IOP in rats. Invest Ophthalmol. Vis. Sci. 2010, 51:308-318.
39. Saika S., Miyamoto T., Kawashima Y., Okada Y., Yamanaka O., Ohnishi Y., Ooshima A. Immunolocalization of TGF-beta1, -beta2, and -beta3, and TGF-beta receptors in human lens capsules with lens implants. Graefes Arch. Clin. Exp. Ophthalmol. 2000, 238:283-293.
40. Sapitro J., Dunmire J.J., Scott S.E., Sutariya V., Geldenhuys W.J., Hewit M., Yue B.Y., Nakamura H. Suppression of transforming growth factor-beta effects in rabbit subconjunctival fibroblasts by activin receptor-like kinase 5 inhibitor. Mol. Vis. 2010, 16:1880-1892.
41. Shepard A.R., Millar J.C., Pang I.H., Jacobson N., Wang W.H., Clark A.F. Adenoviral gene transfer of active human transforming growth factor-(beta)2 elevates intraocular pressure and reduces outflow facility in rodent eyes. Invest Ophthalmol. Vis. Sci. 2010, 51:2067-2076.
42. Shimada H., Staten N.R., Rajagopalan L.E. TGF-beta1 mediated activation of Rho kinase induces TGF-beta2 and endothelin-1 expression in human hepatic stellate cells. J. Hepatol. 2011, 54:521-528.
43. Song J., Deng P.F., Stinnett S.S., Epstein D.L., Rao P.V. Effects of cholesterol-lowering statins on the aqueous humor outflow pathway. Invest Ophthalmol. Vis. Sci. 2005, 46:2424-2432.
44. Stubbs E.B., Von Zee C.L. Prenylation of rho g-proteins: a novel mechanism regulating gene expression and protein stability in human trabecular meshwork cells. Mol. Neurobiol. 2012, 46:28-40.
45. Swaminathan S.S., Oh D.J., Kang M.H., Shepard A.R., Pang I.H., Rhee D.J. TGF-beta2-mediated ocular hypertension is attenuated in SPARC-null mice. Invest Ophthalmol. Vis. Sci. 2014, 55:4084-4097.
46. Tovar-Vidales T., Clark A.F., Wordinger R.J. Transforming growth factor-beta2 utilizes the canonical smad-signaling pathway to regulate tissue transglutaminase expression in human trabecular meshwork cells. Exp. Eye Res. 2011, 93:442-451.
47. Tripathi R.C., Chan W.F., Li J., Tripathi B.J. Trabecular cells express the TGF-beta 2 gene and secrete the cytokine. Exp. Eye Res. 1994, 58:523-528.
48. Tripathi R.C., Li J., Chan W.F., Tripathi B.J. Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp. Eye Res. 1994, 59:723-727.
49. Villarreal G., Chatterjee A., Oh S.S., Oh D.J., Rhee D.J. Pharmacological regulation of SPARC by lovastatin in human trabecular meshwork cells. Invest Ophthalmol. Vis. Sci. 2014, 55:1657-1665.
50. Von Zee C.L., Langert K.A., Stubbs E.B. Transforming growth factor-beta2 induces synthesis and secretion of endothelin-1 in human trabecular meshwork cells. Invest Ophthalmol. Vis. Sci. 2012, 53:5279-5286.
51. Von Zee C.L., Richards M.P., Bu P., Perlman J.I., Stubbs E.B. Increased RhoA and RhoB protein accumulation in cultured human trabecular meshwork cells by lovastatin. Invest Ophthalmol. Vis. Sci. 2009, 50:2816-2823.
52. Von Zee C.L., Stubbs E.B. Geranylgeranylation facilitates proteasomal degradation of rho g-proteins in human trabecular meshwork cells. Invest Ophthalmol. Vis. Sci. 2011, 52:1676-1683.
53. Welge-Lussen U., May C.A., Lutjen-Drecoll E. Induction of tissue transglutaminase in the trabecular meshwork by TGF-beta1 and TGF-beta2. Invest Ophthalmol. Vis. Sci. 2000, 41:2229-2238.
54. Wordinger R.J., Fleenor D.L., Hellberg P.E., Pang I.H., Tovar T.O., Zode G.S., Fuller J.A., Clark A.F. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma. Invest Ophthalmol. Vis. Sci. 2007, 48:1191-1200.
55. Xiao Y.Q., Liu K., Shen J.F., Xu G.T., Ye W. SB-431542 inhibition of scar formation after filtration surgery and its potential mechanism. Invest Ophthalmol. Vis. Sci. 2009, 50:1698-1706.
56. Yamamoto N., Itonaga K., Marunouchi T., Majima K. Concentration of transforming growth factor beta2 in aqueous humor. Ophthalmic Res. 2005, 37:29-33.